Skip to content

Risks of Genetically Modified Foods (GMOs)

Share this article

What are GMOs?

Genetically modified organisms (GMOs) are organisms (i.e. plants, animals or microorganisms) in which the genetic material (DNA) has been altered in a way that does not occur naturally by mating and/or natural recombination.

It allows selected individual genes to be transferred from one organism into another, also between non-related species.

In the context of consumer goods, GMOs often refer to genetically modified crops used in food production. These crops are engineered to possess certain traits that enhance their resistance to pests, diseases, herbicides, or improve their nutritional content. Some common GMO crops include corn, soybeans, canola, and cotton.

Foods produced from or using GM organisms are often referred to as GM foods. Although the bulk of commercially available foods are GM plants, a few GM animals have recently been developed for human consumption.

How are GMO’s produced?

GMO’s involve the intentional alteration of an organism’s genetic material by introducing or modifying specific genes. Here is a general overview of the steps involved in producing GMOs:

  1. Identification of Desired Trait: Scientists identify a specific trait or characteristic that they want to introduce or modify in an organism. This can be traits like resistance to pests or diseases, improved nutritional content, or enhanced tolerance to environmental conditions.
  2. Gene Isolation: The desired gene or genes responsible for the desired trait are identified and isolated. These genes can be sourced from the same organism or from different species, including bacteria, plants, or animals.
  3. Gene Insertion: The isolated gene is inserted into the genome of the target organism. Several techniques can be used for gene insertion, including using a carrier molecule (vector) such as a plasmid, or using specialized delivery methods like gene guns or bacterial transformation.
  4. Genetic Integration: The inserted gene integrates into the genome of the target organism. This step ensures that the new gene becomes a permanent part of the organism’s genetic material and is inherited by subsequent generations.
  5. Selection and Cultivation: After genetic integration, the modified organism is selected and cultivated under controlled conditions to allow for growth and development. During this stage, scientists closely monitor the expression of the desired trait and conduct additional testing to ensure stability and safety.
  6. Regulatory Assessment: Before GMOs can be marketed and sold, they undergo extensive safety assessments and regulatory approval processes. These evaluations vary by country but generally involve comprehensive testing to assess the safety for human health, the environment, and the potential for any unintended effects.

Possible health effects

While concerns have been raised about the potential risks of GMOs to human health, extensive research conducted over several decades has provided substantial evidence that GMOs currently on the market are safe for consumption.

It is important to differentiate between theoretical risks, which are concerns based on hypothetical possibilities, and actual risks supported or refuted by scientific research. Here we discuss some of the theoretical risks that are commonly raised in the medical community.

1.) Increased allergic reactions?

Some concerns have been raised that the introduction of novel genes through genetic modification could potentially lead to the production of new allergens or increase the allergenicity of existing proteins in food.

The potential for increased allergic reactions in GMO food consumption arises from the fact that the introduced genes may produce proteins that are structurally similar to known allergens. If these proteins are expressed in the modified crop and remain stable during food processing and digestion, they could potentially elicit an immune response in susceptible individuals.

Another concern is the possibility of unintended effects on allergenicity due to changes in the overall protein composition of GMOs. Genetic modification can impact the expression of various proteins in a plant, and even small alterations in protein profiles could theoretically lead to the production of new allergens or modify the levels of existing allergens.

Research Findings

Numerous scientific studies have been conducted to evaluate the safety of GMOs, including their potential to induce allergic reactions. The consensus among major scientific organizations is that currently available GMOs on the market are as safe for human consumption as their non-GMO counterparts.

The research conducted so far has not provided conclusive evidence of a widespread increase in allergic reactions due to GMO consumption. In fact, the overall consensus suggests that the process of genetic modification itself does not inherently increase the risk of allergenicity. The regulatory frameworks for assessing GMOs typically include measures to evaluate the potential allergenicity of the newly introduced proteins.

To date, no commercially approved GMO has been found to contain new allergens. The majority of GMOs on the market have undergone extensive safety testing and have been deemed substantially equivalent to their non-GMO counterparts in terms of allergenicity.

It’s important to note that while GMOs have not been shown to cause increased allergic reactions in humans, individuals with known allergies should continue to follow their healthcare provider’s advice regarding food choices and potential allergens, regardless of whether they are GMO or non-GMO. Allergies are complex and can vary from person to person, so it is crucial to address individual sensitivities on a case-by-case basis.

2.) Increased pathogenic bacteria?

Concerns have been raised that genetic modification could potentially lead to unintended consequences, including the development of more robust and virulent strains of bacteria.

One possible concern is that genetic modification might inadvertently enhance the pathogenicity of bacteria through the transfer of antibiotic resistance genes. Genetic engineers sometimes use antibiotic resistance markers as selectable markers during the modification process.

There are concerns that these genes could transfer to pathogenic bacteria, contributing to the spread of antibiotic resistance and potentially making infections more difficult to treat.

Furthermore, critics argue that the introduction of foreign genes into GMOs could lead to unintended effects on microbial communities in the environment and the human gut. Altering the genetic makeup of organisms could potentially disrupt ecological balances and favor the growth of harmful bacteria or the development of antibiotic-resistant strains.

Research Findings

The potential risks associated with GMO consumption and increased pathogenic bacterial strength have been extensively studied. Scientific organizations have reviewed the available research and have not found evidence to support the claim that GMOs lead to an increased risk of pathogenic bacterial strength in humans.

Regarding antibiotic resistance, studies have shown that the use of antibiotic resistance markers in the development of GMOs is highly controlled. Regulatory authorities require thorough assessments to ensure that any antibiotic resistance genes used in GMOs are not transferable to bacteria in the environment or the human gut. This helps mitigate the risk of promoting antibiotic resistance among pathogens.

Moreover, the process of genetic modification itself is highly targeted and specific, typically involving the introduction of a few carefully selected genes. The introduced genes usually code for desirable traits, such as enhanced pest resistance or improved nutritional content, rather than factors that would directly contribute to bacterial pathogenicity.

Studies examining the impact of GMOs on microbial communities, including the gut microbiota, have not provided evidence of significant adverse effects. The overall consensus is that the consumption of GMOs does not have a detrimental impact on the composition or function of microbial populations in the human gut.

It’s worth noting that the potential risks associated with pathogenic bacterial strength are not exclusive to GMOs. The development of antibiotic resistance and the spread of virulent strains of bacteria are multifactorial issues influenced by various factors, including the misuse and overuse of antibiotics in human and veterinary medicine.

3.) Increased toxic metabolites?

Critics have raised concerns that the genetic modification process could inadvertently introduce or enhance the production of toxins or toxic metabolites in GMOs, posing potential health risks to consumers.

One concern is that the introduction of novel genes through genetic modification could lead to the production of new substances that may be toxic or allergenic. The genetic modification process involves the insertion of foreign genes, and it is possible that the expression of these genes could result in the production of unintended substances with harmful properties.

Furthermore, some argue that the genetic modification process could alter the metabolic pathways of the modified organisms, potentially leading to the production of toxic metabolites. Changes in gene expression patterns or the introduction of new enzymes through genetic modification may affect the synthesis and accumulation of various compounds in GMOs, including those that could be toxic or harmful to human health.

Research Findings

Extensive research has been conducted to evaluate the safety of GMOs, including the potential for the accumulation of unwanted toxins or toxic metabolites. The consensus among major scientific organizations is that currently available GMOs on the market are safe for human consumption and do not pose an increased risk of toxin accumulation.

Studies investigating the potential for unintended effects in GMOs have not found evidence of significant differences in the accumulation of toxins or toxic metabolites compared to their non-GMO counterparts. Regulatory frameworks for assessing GMOs typically include evaluations of potential toxins and toxic metabolites, with a focus on substances known to be of concern.

Moreover, the regulatory approval process for GMOs involves thorough safety assessments, which include analyzing the compositional profiles of GMOs. These evaluations compare the levels of key nutrients, antinutrients, and potentially harmful substances in GMOs and their non-GMO counterparts. If any significant differences or potential concerns are identified, additional studies and analyses may be required before a GMO can be approved for commercial use.

To date, there is no scientific evidence to suggest that GMOs currently on the market pose a greater risk of unwanted toxin accumulation or the production of toxic metabolites compared to conventionally bred crops. The genetic modification process itself does not inherently increase the risk of toxicity, and the safety evaluations in place aim to identify and address any potential concerns.

It’s important to note that the overall safety of any food product, whether GMO or non-GMO, relies on a comprehensive regulatory framework and adherence to good agricultural practices. Monitoring and regulatory systems play a crucial role in ensuring the safety of the food supply.

Environmental risks

Concerns have been raised regarding their potential risks to the environment. It is important to note that the potential risks associated with GMOs can vary depending on the specific organism and its intended use. Here are some of the possible risks to the environment that have been discussed.

Spread of GMO genes

Research has shown that gene flow between GMOs and wild or non-GMO relatives can occur, but the extent of gene flow depends on several factors such as the crop species, the genetic distance between the GMO and the wild relative, and the presence of reproductive barriers.

However, studies have demonstrated that the overall frequency of gene flow is typically low. Additionally, the transfer of introduced genes from GMOs to wild populations does not necessarily result in negative ecological impacts or significant changes in the genetic diversity of wild populations.

Impact on other organisms

Extensive research has been conducted to assess the potential impacts of GMOs on non-target organisms. For insect-resistant GMO crops, studies have shown that the toxins produced by these crops are specific to certain target pests and have minimal effects on beneficial insects, such as bees and butterflies. Rigorous testing and environmental risk assessments are conducted during the regulatory approval process to ensure the safety of GMOs and minimize potential harm to non-target organisms.

Development of resistant weeds

The development of resistance in pests or weeds is a concern with any pest management strategy, including GMOs. Research shows that the deployment of insect-resistant GMOs has led to a reduction in the use of chemical insecticides and improved pest control in many cases.

However, the emergence of resistance can occur over time. To address this, integrated pest management strategies that combine multiple approaches, including the judicious use of GMOs, are recommended to mitigate the risk of resistance development.

Disruption of ecological balance

The potential disruption of ecological balance is an important consideration when assessing the environmental impact of GMOs. Studies have examined the interactions between GMOs and non-target organisms, and overall, they have not shown significant adverse effects on ecological balance or disruptions in food chains.

However, the potential ecological impacts of GMOs can vary depending on the specific organism and its traits, and comprehensive environmental risk assessments are conducted to evaluate and address these concerns.

Persistence and spread

Research has shown that the persistence and spread of GMOs in the environment are generally similar to their non-GMO counterparts. GMOs do not inherently possess unique mechanisms for enhanced persistence or spread. Their persistence depends on factors such as seed survival, crop management practices, and natural ecological processes.

Regulatory frameworks include measures to prevent the uncontrolled spread of GMOs beyond intended cultivation areas and to manage potential risks associated with persistence and invasiveness.

Current GMO crops

There are many commonly consumed food crops that are often genetically modified (GM) or genetically engineered (GE). The specific modifications conferred by genetic engineering vary depending on the crop and the intended purpose. Here are some examples of GM crops and the modifications they typically possess:

  • Corn (maize): GM corn varieties are widely cultivated. The main modifications in GM corn confer traits such as insect resistance and herbicide tolerance. Insect-resistant corn expresses a toxin derived from the soil bacterium Bacillus thuringiensis (Bt), which helps protect the plant against certain insect pests. Herbicide-tolerant corn is engineered to withstand specific herbicides, allowing farmers to control weeds more effectively.
  • Soybeans: GM soybeans are prevalent in many countries. The primary modification in GM soybeans is herbicide tolerance. These soybeans are engineered to tolerate certain herbicides, such as glyphosate, which simplifies weed control during cultivation.
  • Cotton: While cotton is primarily grown for fiber, it is also a significant source of vegetable oil and animal feed. GM cotton varieties are widely grown, primarily for their insect resistance traits. Similar to Bt corn, Bt cotton produces a toxin derived from Bacillus thuringiensis, providing protection against specific insect pests, particularly bollworms.
  • Canola: GM canola is cultivated in several countries. The main modification in GM canola is herbicide tolerance, enabling more efficient weed control during cultivation. This herbicide tolerance trait allows farmers to use specific herbicides to manage weed competition.
  • Papaya: In certain regions, genetically modified papaya is grown to resist the papaya ringspot virus, a devastating disease that affects papaya crops. The genetic modification confers resistance to the virus, helping to protect the plants and ensure better yields.
  • Sugar beets: GM sugar beets are widely grown and are used as a significant source of sugar production. The main modification in GM sugar beets provides herbicide tolerance, allowing effective weed management.
  • Alfalfa: GM alfalfa varieties are engineered to be herbicide-tolerant, allowing for more effective weed control during cultivation. This modification helps farmers manage weed competition and improve crop yields.
  • Apples: Some varieties of genetically modified apples have been developed to reduce browning when cut or bruised. This trait is achieved by suppressing the production of enzymes responsible for browning, enhancing the visual appeal and shelf life of sliced apples.
  • Potatoes: GM potatoes have been developed with various traits, including resistance to specific pests and reduced bruising. Insect-resistant varieties produce the Bt toxin to protect against pests, while reduced bruising traits help minimize damage during harvesting and storage.
  • Squash: Certain varieties of genetically modified squash, such as zucchini and yellow summer squash, have been developed to resist viruses that can devastate crops. These GM varieties offer increased protection against viral infections, leading to improved yields.
  • Tomatoes: GM tomatoes have been developed with traits such as improved shelf life and enhanced nutritional content. Some varieties are engineered to delay ripening, reducing spoilage and extending the time available for shipping and storage. Other modifications aim to increase the levels of certain beneficial compounds, such as antioxidants or vitamins.
  • Rice: Genetically modified rice varieties have been developed with traits such as improved tolerance to environmental stressors, resistance to certain pests, or enhanced nutritional profiles. For example, Golden Rice is a genetically modified rice variety engineered to produce beta-carotene, a precursor of vitamin A, to address vitamin A deficiency in developing countries.

See also


Share this article

Leave a Reply

Your email address will not be published. Required fields are marked *